Literature DB >> 26755690

Long-term Results After Hyaluronan-based MACT for the Treatment of Cartilage Lesions of the Patellofemoral Joint.

Elizaveta Kon1, Giuseppe Filardo2, Alberto Gobbi3, Massimo Berruto4, Luca Andriolo2, Paolo Ferrua4, Ilaria Crespiatico3, Maurilio Marcacci2.   

Abstract

BACKGROUND: Cartilage lesions of the patellofemoral joint are a challenging condition. Hyaluronan-based matrix-assisted autologous chondrocyte transplantation (MACT) has been shown to offer a significant improvement in the short term but has a tendency to worsen at midterm follow-up. HYPOTHESIS: Patients treated with MACT for lesions of the articular surface of the patellofemoral joint will present further clinical worsening at long-term follow-up. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: Thirty-two patients with full-thickness chondral lesions in the patellofemoral joint were treated with hyaluronan-based MACT and were prospectively evaluated preoperatively and at 2-, 5-, and 10-year follow-up. The mean defect size was 4.45 cm(2). There were 20 lesions located on the patella and 8 on the trochlea, and 4 patients had multiple lesions: 3 with patellar and trochlear lesions and 1 with patellar and lateral femoral condyle lesions. Results were evaluated using International Knee Documentation Committee (IKDC) subjective scores, EuroQol visual analog scale (EQ VAS) scores, and Tegner scores. Surgical and clinical failures were documented.
RESULTS: All scores showed a statistically significant improvement at 2-, 5-, and 10-year follow-up with respect to the preoperative level. No worsening was observed at the last follow-up, and results were stable up to 10 years. The improvement in mean (±SD) outcome scores from preoperatively to 2-, 5-, and 10-year follow-up was as follows: IKDC, from 46.0 ± 19.8 to 77.1 ± 17.4, 72.0 ± 20.4, and 78.6 ± 16.4, respectively; Tegner, from 2.5 ± 1.4 to 4.7 ± 1.8, 4.7 ± 1.6, and 4.4 ± 1.5, respectively; and EQ VAS, from 56.9 ± 18.4 to 81.7 ± 13.2, 79.2 ± 17.9, and 78.9 ± 1.7, respectively. Four patients did not achieve significant clinical improvement, and 1 of these patients required further surgical treatment. All failures were female patients with patellar defects, and 3 of them had degenerative lesions and underwent a previous or combined realignment procedure.
CONCLUSION: The clinical results of hyaluronan-based MACT treatment of chondral lesions of the patellofemoral joint do not worsen over time but remain stable and show a low rate of failure at long-term follow-up.
© 2016 The Author(s).

Entities:  

Keywords:  MACT; chondral lesions; chondrocytes; long-term follow-up; patellofemoral joint; scaffold

Mesh:

Substances:

Year:  2016        PMID: 26755690     DOI: 10.1177/0363546515620194

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  22 in total

1.  Clinical outcome and success rates of ACI for cartilage defects of the patella: a subgroup analysis from a controlled randomized clinical phase II trial (CODIS study).

Authors:  Philipp Niemeyer; Volker Laute; Wolfgang Zinser; Christoph Becher; Peter Diehl; Thomas Kolombe; Jakob Fay; Rainer Siebold; Stefan Fickert
Journal:  Arch Orthop Trauma Surg       Date:  2019-08-26       Impact factor: 3.067

2.  Chitosan based scaffold applied in patellar cartilage lesions showed positive clinical and MRI results at minimum 2 years of follow up.

Authors:  Alberto Poggi; Alessandro Di Martino; Luca Andriolo; Davide Reale; Giuseppe Filardo; Elizaveta Kon; Stefano Zaffagnini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-06-09       Impact factor: 4.342

Review 3.  Early osteoarthritis of the patellofemoral joint.

Authors:  Elizabeth A Arendt; Massimo Berruto; Giuseppe Filardo; Mario Ronga; Stefano Zaffagnini; Jack Farr; Paolo Ferrua; Alberto Grassi; Vincenzo Condello
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-27       Impact factor: 4.342

4.  Matrix-assisted chondrocyte transplantation with bone grafting for knee osteochondritis dissecans: stable results at 12 years.

Authors:  Luca Andriolo; Alessandro Di Martino; Sante Alessandro Altamura; Angelo Boffa; Alberto Poggi; Maurizio Busacca; Stefano Zaffagnini; Giuseppe Filardo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-08-18       Impact factor: 4.342

5.  Accurate Reporting of Concomitant Procedures Is Highly Variable in Studies Investigating Knee Cartilage Restoration.

Authors:  William L Sheppard; Betina B Hinckel; Armin Arshi; Seth L Sherman; Kristofer J Jones
Journal:  Cartilage       Date:  2019-04-11       Impact factor: 4.634

6.  Cell-Free Scaffolds in Cartilage Knee Surgery: A Systematic Review and Meta-Analysis of Clinical Evidence.

Authors:  Luca Andriolo; Davide Reale; Alessandro Di Martino; Angelo Boffa; Stefano Zaffagnini; Giuseppe Filardo
Journal:  Cartilage       Date:  2019-06-05       Impact factor: 4.634

7.  Effect of the defect localization and size on the success of third-generation autologous chondrocyte implantation in the knee joint.

Authors:  Thomas R Niethammer; David Gallik; Y Chevalier; Martin Holzgruber; Andrea Baur-Melnyk; Peter E Müller; Matthias F Pietschmann
Journal:  Int Orthop       Date:  2020-12-06       Impact factor: 3.075

8.  Role of Matrix-Associated Autologous Chondrocyte Implantation with Spheroids in the Treatment of Large Chondral Defects in the Knee: A Systematic Review.

Authors:  Lucienne Angela Vonk; Giulietta Roël; Jacques Hernigou; Christian Kaps; Philippe Hernigou
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

9.  Matrix-Associated Autologous Chondrocyte Implantation with Spheroid Technology Is Superior to Arthroscopic Microfracture at 36 Months Regarding Activities of Daily Living and Sporting Activities after Treatment.

Authors:  Arnd Hoburg; Philipp Niemeyer; Volker Laute; Wolfgang Zinser; Christoph Becher; Thomas Kolombe; Jakob Fay; Stefan Pietsch; Tomasz Kuźma; Wojciech Widuchowski; Stefan Fickert
Journal:  Cartilage       Date:  2020-01-01       Impact factor: 3.117

10.  Scaffolds for Knee Chondral and Osteochondral Defects: Indications for Different Clinical Scenarios. A Consensus Statement.

Authors:  Giuseppe Filardo; Luca Andriolo; Peter Angele; Massimo Berruto; Mats Brittberg; Vincenzo Condello; Susan Chubinskaya; Laura de Girolamo; Alessandro Di Martino; Berardo Di Matteo; Justus Gille; Alberto Gobbi; Christian Lattermann; Norimasa Nakamura; Stefan Nehrer; Giuseppe M Peretti; Nogah Shabshin; Peter Verdonk; Kenneth Zaslav; Elizaveta Kon
Journal:  Cartilage       Date:  2020-01-15       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.